Sfoglia per Autore OLIVA, STEFANIA
Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients
2024-01-01 D'Agostino, Mattia; Bertuglia, Giuseppe; Rota-Scalabrini, Delia; Belotti, Angelo; Morè, Sonia; Corradini, Paolo; Oliva, Stefania; Ledda, Antonio; Grasso, Mariella; Pavone, Vincenzo; Ronconi, Sonia; Vincelli, Iolanda Donatella; Ballanti, Stelvio; Velluti, Cristina; Cellini, Claudia; Gozzetti, Alessandro; Palmas, Angelo D; Gamberi, Barbara; Mancuso, Katia; Paris, Laura; Zambello, Renato; Petrucci, Maria Teresa; Bruno, Benedetto; Musto, Pellegrino; Gay, Francesca
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
2024-01-01 Ziccheddu, Bachisio; Giannotta, Claudia; D'Agostino, Mattia; Bertuglia, Giuseppe; Saraci, Elona; Oliva, Stefania; Genuardi, Elisa; Papadimitriou, Marios; Diamond, Benjamin; Corradini, Paolo; Coffey, David; Landgren, Ola; Bolli, Niccolò; Bruno, Benedetto; Boccadoro, Mario; Massaia, Massimo; Maura, Francesco; Larocca, Alessandra
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial
2023-01-01 Zamagni, Elena; Oliva, Stefania; Gay, Francesca; Capra, Andrea; Rota-Scalabrini, Delia; D'Agostino, Mattia; Belotti, Angelo; Galli, Monica; Racca, Manuela; Zambello, Renato; Gamberi, Barbara; Albano, Domenico; Bertamini, Luca; Versari, Annibale; Grasso, Mariella; Sgherza, Nicola; Priola, Claudia; Fioritoni, Francesca; Patriarca, Francesca; De Cicco, Gabriella; Villanova, Tania; Pascarella, Anna; Zucchetta, Pietro; Tacchetti, Paola; Fanti, Stefano; Mancuso, Katia; Barbato, Simona; Boccadoro, Mario; Musto, Pellegrino; Cavo, Michele; Nanni, Cristina
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
2022-01-01 Bertamini, Luca; Oliva, Stefania; Rota-Scalabrini, Delia; Paris, Laura; Morè, Sonia; Corradini, Paolo; Ledda, Antonio; Gentile, Massimo; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Curci, Paola; Gilestro, Milena; Capra, Andrea; Galieni, Piero; Pisani, Francesco; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Luppi, Mario; Zambello, Renato; Fazio, Francesca; Belotti, Angelo; Tacchetti, Paola; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
2021-01-01 Sonneveld, Pieter; Dimopoulos, Meletios A; Beksac, Meral; van der Holt, Bronno; Aquino, Sara; Ludwig, Heinz; Zweegman, Sonja; Zander, Thilo; Zamagni, Elena; Wester, Ruth; Hajek, Roman; Pantani, Lucia; Dozza, Luca; Gay, Francesca; Cafro, AnneMaria; De Rosa, Luca; Morelli, Annamaria; Gregersen, Henrik; Gulbrandsen, Nina; Cornelisse, Petra; Troia, Rosella; Oliva, Stefania; van de Velden, Vincent; Wu, KaLung; Ypma, Paula F; Bos, Gerard; Levin, Mark-David; Pour, Luca; Driessen, Christoph; Broijl, Annemiek; Croockewit, Alexandra; Minnema, Monique C; Waage, Anders; Hveding, Cecilie; van de Donk, Niels W C J; Offidani, Massimo; Palumbo, Giuseppe A; Spencer, Andrew; Boccadoro, Mario; Cavo, Michele
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma
2021-01-01 Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P.
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial
2021-01-01 Oliva, Stefania; Hofste op Bruinink, Davine; Rihova, Lucie; D'Agostino, Mattia; Pantani, Lucia; Capra, Andrea; van der Holt, Bronno; Troia, Rossella; Petrucci, Maria Teresa; Villanova, Tania; Vsianska, Pavla; Jugooa, Romana; Brandt-Hagens, Claudia; Gilestro, Milena; Offidani, Massimo; Ribolla, Rossella; Galli, Monica; Hajek, Roman; Gay, Francesca; Cavo, Michele; Omedé, Paola; van der Velden, Vincent H J; Boccadoro, Mario; Sonneveld, Pieter
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials
2021-01-01 Chen Y.-T.; Valent E.T.; van Beers E.H.; Kuiper R.; Oliva S.; Haferlach T.; Chng W.-J.; van Vliet M.H.; Sonneveld P.; Larocca A.
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma
2021-01-01 Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò
Minimal Residual Disease in Multiple Myeloma: Ready for Prime Time?
2021-01-01 Mina R.; Bonello F.; Oliva S.
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?
2021-01-01 Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M.
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
2020-01-01 Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P.
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set
2020-01-01 Chari A.; Samur M.K.; Martinez-Lopez J.; Cook G.; Biran N.; Yong K.; Hungria V.; Engelhardt M.; Gay F.; Feria A.G.; Oliva S.; Oostvogels R.; Gozzetti A.; Rosenbaum C.; Kumar S.; Stadtmauer E.A.; Einsele H.; Beksac M.; Weisel K.; Anderson K.C.; Mateos M.-V.; Moreau P.; San-Miguel J.; Munshi N.C.; Avet-Loiseau H.
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate
2020-01-01 Milani P.; Fazio F.; Basset M.; Berno T.; Larocca A.; Foli A.; Riva M.; Benigna F.; Oliva S.; Nuvolone M.; Rodigari L.; Petrucci M.T.; Merlini G.; Palladini G.
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
2020-01-01 D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
2020-01-01 Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A.
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives
2020-01-01 Mina, Roberto; Oliva, Stefania; Boccadoro, Mario
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
2020-01-01 Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A.
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies
2019-01-01 D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F.
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis
2019-01-01 Gambella M.; Omede P.; Spada S.; Muccio V.E.; Gilestro M.; Saraci E.; Grammatico S.; Larocca A.; Conticello C.; Bernardini A.; Gamberi B.; Troia R.; Liberati A.M.; Offidani M.; Rocci A.; Palumbo A.; Cavo M.; Sonneveld P.; Boccadoro M.; Oliva S.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients | 2024 | D'Agostino, Mattia; Bertuglia, Giuseppe; Rota-Scalabrini, Delia; Belotti, Angelo; Morè, Sonia; Corradini, Paolo; Oliva, Stefania; Ledda, Antonio; Grasso, Mariella; Pavone, Vincenzo; Ronconi, Sonia; Vincelli, Iolanda Donatella; Ballanti, Stelvio; Velluti, Cristina; Cellini, Claudia; Gozzetti, Alessandro; Palmas, Angelo D; Gamberi, Barbara; Mancuso, Katia; Paris, Laura; Zambello, Renato; Petrucci, Maria Teresa; Bruno, Benedetto; Musto, Pellegrino; Gay, Francesca | |
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma | 2024 | Ziccheddu, Bachisio; Giannotta, Claudia; D'Agostino, Mattia; Bertuglia, Giuseppe; Saraci, Elona; Oliva, Stefania; Genuardi, Elisa; Papadimitriou, Marios; Diamond, Benjamin; Corradini, Paolo; Coffey, David; Landgren, Ola; Bolli, Niccolò; Bruno, Benedetto; Boccadoro, Mario; Massaia, Massimo; Maura, Francesco; Larocca, Alessandra | |
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial | 2023 | Zamagni, Elena; Oliva, Stefania; Gay, Francesca; Capra, Andrea; Rota-Scalabrini, Delia; D'Agostino, Mattia; Belotti, Angelo; Galli, Monica; Racca, Manuela; Zambello, Renato; Gamberi, Barbara; Albano, Domenico; Bertamini, Luca; Versari, Annibale; Grasso, Mariella; Sgherza, Nicola; Priola, Claudia; Fioritoni, Francesca; Patriarca, Francesca; De Cicco, Gabriella; Villanova, Tania; Pascarella, Anna; Zucchetta, Pietro; Tacchetti, Paola; Fanti, Stefano; Mancuso, Katia; Barbato, Simona; Boccadoro, Mario; Musto, Pellegrino; Cavo, Michele; Nanni, Cristina | |
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma | 2022 | Bertamini, Luca; Oliva, Stefania; Rota-Scalabrini, Delia; Paris, Laura; Morè, Sonia; Corradini, Paolo; Ledda, Antonio; Gentile, Massimo; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Curci, Paola; Gilestro, Milena; Capra, Andrea; Galieni, Piero; Pisani, Francesco; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Luppi, Mario; Zambello, Renato; Fazio, Francesca; Belotti, Angelo; Tacchetti, Paola; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca | |
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma | 2021 | Sonneveld, Pieter; Dimopoulos, Meletios A; Beksac, Meral; van der Holt, Bronno; Aquino, Sara; Ludwig, Heinz; Zweegman, Sonja; Zander, Thilo; Zamagni, Elena; Wester, Ruth; Hajek, Roman; Pantani, Lucia; Dozza, Luca; Gay, Francesca; Cafro, AnneMaria; De Rosa, Luca; Morelli, Annamaria; Gregersen, Henrik; Gulbrandsen, Nina; Cornelisse, Petra; Troia, Rosella; Oliva, Stefania; van de Velden, Vincent; Wu, KaLung; Ypma, Paula F; Bos, Gerard; Levin, Mark-David; Pour, Luca; Driessen, Christoph; Broijl, Annemiek; Croockewit, Alexandra; Minnema, Monique C; Waage, Anders; Hveding, Cecilie; van de Donk, Niels W C J; Offidani, Massimo; Palumbo, Giuseppe A; Spencer, Andrew; Boccadoro, Mario; Cavo, Michele | |
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma | 2021 | Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P. | |
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial | 2021 | Oliva, Stefania; Hofste op Bruinink, Davine; Rihova, Lucie; D'Agostino, Mattia; Pantani, Lucia; Capra, Andrea; van der Holt, Bronno; Troia, Rossella; Petrucci, Maria Teresa; Villanova, Tania; Vsianska, Pavla; Jugooa, Romana; Brandt-Hagens, Claudia; Gilestro, Milena; Offidani, Massimo; Ribolla, Rossella; Galli, Monica; Hajek, Roman; Gay, Francesca; Cavo, Michele; Omedé, Paola; van der Velden, Vincent H J; Boccadoro, Mario; Sonneveld, Pieter | |
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials | 2021 | Chen Y.-T.; Valent E.T.; van Beers E.H.; Kuiper R.; Oliva S.; Haferlach T.; Chng W.-J.; van Vliet M.H.; Sonneveld P.; Larocca A. | |
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma | 2021 | Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò | |
Minimal Residual Disease in Multiple Myeloma: Ready for Prime Time? | 2021 | Mina R.; Bonello F.; Oliva S. | |
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved? | 2021 | Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M. | |
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study | 2020 | Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P. | |
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set | 2020 | Chari A.; Samur M.K.; Martinez-Lopez J.; Cook G.; Biran N.; Yong K.; Hungria V.; Engelhardt M.; Gay F.; Feria A.G.; Oliva S.; Oostvogels R.; Gozzetti A.; Rosenbaum C.; Kumar S.; Stadtmauer E.A.; Einsele H.; Beksac M.; Weisel K.; Anderson K.C.; Mateos M.-V.; Moreau P.; San-Miguel J.; Munshi N.C.; Avet-Loiseau H. | |
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate | 2020 | Milani P.; Fazio F.; Basset M.; Berno T.; Larocca A.; Foli A.; Riva M.; Benigna F.; Oliva S.; Nuvolone M.; Rodigari L.; Petrucci M.T.; Merlini G.; Palladini G. | |
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing | 2020 | D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca | |
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents | 2020 | Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A. | |
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives | 2020 | Mina, Roberto; Oliva, Stefania; Boccadoro, Mario | |
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma | 2020 | Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A. | |
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies | 2019 | D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F. | |
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis | 2019 | Gambella M.; Omede P.; Spada S.; Muccio V.E.; Gilestro M.; Saraci E.; Grammatico S.; Larocca A.; Conticello C.; Bernardini A.; Gamberi B.; Troia R.; Liberati A.M.; Offidani M.; Rocci A.; Palumbo A.; Cavo M.; Sonneveld P.; Boccadoro M.; Oliva S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile